Grant-backed growth Recent NIH grant financing of 3.5M indicates strong validation and potential for expanded collaboration or contract research services; use this momentum to propose expanded allergy research projects and reagent/service bundles.

Circular lab Partnership with Polycarbin to recycle lab plastics suggests openness to sustainability programs; pitch end-to-end sustainable sourcing, waste reduction services, and green certification offerings to customers with ESG goals.

Allergen ecosystem Broad allergen-focused portfolio including MARIA for Foods, ELISA 2.0, and human IgE monoclonal antibodies positions INDOOR Biotechnologies as a supplier for both academic and industry clients; target allergy vaccine manufacturers and biopharma firms needing diagnostic and research reagents.

Strategic partnerships Existing distributors and collaborations (LGC Limited, GX Group) indicate a channel-friendly model; propose channel partner programs, co-marketing, and regional expansion to accelerate reach in ears, nose, and throat (ENT) and indoor air quality markets.

Indoor air focus Specialization in environmental sciences and indoor air quality aligns with rising demand for indoor air monitoring and allergy diagnostics; present solutions to Fortune 500 facilities, universities, and government labs seeking validated IAQ testing and research services.